Bay Street News, August, 2020

SINGAPORE, Aug. 07, 2020 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing […]

LONDON, Aug. 07, 2020 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (“Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based […]

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Aug. 07, 2020 […]

 Geneva, Switzerland and Boston, MA –  August 7, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and […]

MONTREAL, Aug. 06, 2020 (GLOBE NEWSWIRE) — New Look Vision Group Inc. (“New Look Vision” or the “Company”) (TSX: BCI), […]

HOUSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) — Houston Wire & Cable Company (NASDAQ: HWCC) (the “Company”) announced operating results for the […]

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Aug. 06, […]

CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on […]

ROAD TOWN, British Virgin Islands, Aug. 06, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA32) (the “Company” […]

HAMILTON, Bermuda, Aug. 06, 2020 (GLOBE NEWSWIRE) — Sirius International Insurance Group, Ltd. (Nasdaq: SG) (“Sirius Group”, the “Company”, or […]